novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

As artérias como modeladoras do risco cardio e cerebrovascular

21 Janeiro 2014

João Maldonado
Cardiologista
Clínica da Aveleira
Coimbra

Hipertensão Arterial - Protecção dos órgaos - alvo

25 Novembro 2013
0

Associações fixas no tratamento da HTA

21 Janeiro 2014
0

-->